BC
RGEN icon

Brookfield Corp’s Repligen RGEN Stock Holding History

Brookfield Corp’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,546
Closed -$502K – 437
2023
Q2 		$502K Sell
3,546
-4,582
-56% -$735K ﹤0.01% 503
2023
Q1 		$1.37M Buy
+8,128
New +$1.45M 0.01% 464
2022
Q3 		– Sell
-22,251
Closed -$3.61M – 746
2022
Q2 		$3.61M Buy
+22,251
New +$3.52M 0.02% 313
2021
Q4 		– Sell
-7,797
Closed -$2.25M – 717
2021
Q3 		$2.25M Buy
7,797
+866
+12% +$222K 0.01% 329
2021
Q2 		$1.38M Buy
+6,931
New +$1.34M 0.01% 419

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Brookfield Corp's RGEN Position: Q3 2023 in Review

Brookfield Corp sold out of Repligen (RGEN) in Q3 2023, closing a stake of 3,546 shares — an estimated $502K sold.

Brookfield Corp first reported a position in RGEN in Q2 2021 and held it in 5 quarters. The position peaked at $3.61M in Q2 2022. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Brookfield Corp reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 3,546 Repligen shares in Q3 2023, an estimated $502K.
  • Brookfield Corp first reported a position in Repligen in Q2 2021 and held it in 5 quarters.
  • Brookfield Corp's Repligen position peaked at $3.61M in Q2 2022.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.